THMO - thermogenesis.com Operating income before deduction of amortization

Graphic logo of thermogenesis.com (THMO)

Does streamlined component outsourcing allow ThermoGenesis (THMO) to offset operating losses and volatility? The answer is provided by monitoring operating profit in cash on GURU.Markets, where reflects the latest metric value. This chart confirms the company's status as a leader in stem cell separation, creating a foundation for the development of cell therapy and biobanking.

THMO Cesca Therapeutics Operating profit before deduction of amortization (07/04/2022 - 11/10/2026)

ThermoGenesis Holdings (THMO) - metric breakdowns and financial figures

- current price and projected stock value:
Price Cesca Therapeutics|THMO - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization ThermoGenesis|THMO - Enterprise Value
- balance sheet equity data:
Accounting Value per Share ThermoGenesis|THMO - Company Net Assets|Market Value to Book Value thermogenesis.com|THMO - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio ThermoGenesis|THMO - Long-Term Debt to Capital|Current Liabilities to Capital ThermoGenesis Holdings, Inc.|THMO - Company Aggregate Debts|Debt to Book Value Ratio ThermoGenesis|THMO - Company Long-Term Debts|Short-Term Debt Volume ThermoGenesis|Quick Liquidity Indicator thermogenesis.com
- earnings and multiples data:
THMO - Net Profit|Projected Future Earnings ThermoGenesis|THMO - Price to Earnings Ratio|Future Price to Earnings thermogenesis.com|THMO - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation ThermoGenesis|THMO - Operating profit EBITDA|Net earnings per one share for the last twelve months ThermoGenesis|THMO - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year thermogenesis.com|THMO - Net earnings per share growth this year|Earnings growth forecast for next year ThermoGenesis
Summary company analytics:Cesca Therapeutics - THMO
Mass-produced product of ThermoGenesis

Market expectations for ThermoGenesis (THMO) as a leader in biobanking and regenerative therapy must be validated by a real capacity to generate cash flows. The current value of for operating income before taxes and depreciation reflects the daily net cash generation, excluding accounting lags and amortization, which allows for an objective assessment of the financial stability of automated stem cell storage systems.

Who ThermoGenesis competes with

Company profit before taxes, interest and amortization ABT (Abbott Corp.)|Thermo Fisher Scientific - Operating profit EBITDA|Operating income before deduction of amortization gehealthcare.com GEHC|MTD: Operating profit EBITDA|Operating profit before deduction of amortization Waters Corp|Operating profit before deduction of amortization TECH|BRKR: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Azenta, Inc. (AZTA)|Operating profit before deduction of amortization vareximaging.com VREX|Operating profit EBITDA SMLR (Semler Scientific)|Butterfly Network Inc (BFLY) - Profit before interest, taxes and amortization|Mesa Labs Corp - Operating profit EBITDA|QSI (Quantum-Si Corporation) - Operating profit before amortization|NNOX: Operating profit EBITDA|QTRX - Operating income before deduction of amortization|MASS (908 Devices) - Operating profit EBITDA|Operating profit before deduction of amortization CapsoVision Medical (CV)|Operating profit EBITDA MXCT|Operating profit EBITDA rapidmicrobio.com (RPID)|Profit before payment of interest, taxes and amortization Seer, Inc. SEER|hyperfine.io - Profit before payment of interest, taxes and amortization|FONR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization DXR (Daxor Corporation)|MDAI: Operating profit EBITDA|Profit before interest, taxes and amortization Organovo Holdings Inc. (VIVS)|Profit before payment of interest, taxes and amortization Aclarion|AKYA - Operating profit before depreciation charges|Operating profit before deduction of amortization TLIS (Talis Biomedical)|Operating profit EBITDA T2 Biosystems Inc. (TTOO)